Matthew J Hawryluk

This inventor holds 17 USPTO granted patents and 13 published patent applications, plus 5 CIPO patents and 7 EPO patents. Top assignees: Foundation Medicine, Inc., Ucl Business Plc. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew J Hawryluk. Retrieved from https://idiyas.com/inventor/matthew-j-hawryluk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 85(Granted Patents)

Location History:

Watertown, MA (US) (2014 - 2023)
Cambridge, MA (US) (2021 - 2023)
Newton, MA (US) (2024)

Company Filing History:

17 out of 47

Foundation Medicine, Inc.

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12548682 - System and method for outcome tracking and analysis (2026-02-10),

2. 12274699 - Methods of treating cholangiocarcinoma (2025-04-14),

3. 12239648 - KIF5B-RET fusion molecules and uses thereof (2025-03-04),

4. 12087453 - System and method for outcome tracking and analysis (2024-09-10),

5. 11771698 - Methods of treating cholangiocarcinoma (2023-10-03),

6. 11766439 - Human papilloma virus as predictor of cancer prognosis (2023-09-26),

7. 11578372 - NTRK1 fusion molecules and uses thereof (2023-02-14),

8. 11450438 - System and method for outcome tracking and analysis (2022-09-20),

9. 11158425 - System and method for managing genomic information (2021-10-26),

10. 11058687 - Human papilloma virus as predictor of cancer prognosis (2021-07-13),

11. 10980804 - Methods of treating cholangiocarcinoma (2021-04-20),

12. 9907798 - Methods of treating head and neck cancer (2018-03-06),

13. 9884060 - KIF5B-RET fusion molecules and uses thereof (2018-02-06),

14. 9861633 - Methods of treating urothelial carcinoma (2018-01-09),

15. 9410954 - Human papilloma virus as predictor of cancer prognosis (2016-08-09),

Certainly! Here is the article about inventor Matthew J Hawryluk:

Title: Unveiling the Ingenious Mind of Inventor Matthew J Hawryluk

Introduction: Matthew J Hawryluk, a distinguished inventor hailing from Watertown, MA (US), has left an indelible mark in the realm of innovation with his remarkable contributions.

Latest Patents:

1. Methods of treating cholangiocarcinoma - Methods and compositions for treating cholangiocarcinoma.

2. Human papillomavirus as a predictor of cancer prognosis - Methods of treating head and neck cancer are disclosed.

Career Highlights: With an impressive portfolio of 13 patents to his name, Matthew J Hawryluk has showcased his expertise in developing groundbreaking solutions in the field of healthcare and oncology.

Collaborations: Throughout his career, Matthew J Hawryluk has collaborated with industry stalwarts such as Foundation Medicine, Inc. and UCL Business Plc. Working alongside accomplished individuals like Philip James Stephens and Doron Lipson, he has fostered a culture of innovation and excellence.

Conclusion: Matthew J Hawryluk's innovative spirit and dedication to pioneering advancements in the medical domain underscore his invaluable contributions to the world of inventions. His unwavering commitment to improving cancer treatments solidifies his position as a visionary inventor shaping the future of healthcare.

If you need any more information or have any other requests, feel free to ask!

Profile summary based on public USPTO records.